REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

Share Price Information for Rbg Holdings (RBGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.882%)
Open: 8.75
High: 8.75
Low: 8.75
Prev. Close: 8.75
RBGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading & Dividend Update

5 Dec 2022 07:00

RNS Number : 5217I
RBG Holdings PLC
05 December 2022
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

5 December 2022

RBG Holdings plc

("RBG" or the "Group")

Trading & Dividend Update

 

RBG Holdings plc (AIM: RBGP), the professional services group, today publishes an update on current trading and outlook.

 

RBG's strategy has been to deliver revenues and profit from a diversified portfolio of professional services businesses, reducing overall volatility of earnings and the impact of any losses from any one business. This strategy has served the Group successfully since its admission to AIM in 2018 with the Group achieving profitable top line growth each year. 

 

Professional Services - RBG Legal Services Limited ("RBGLS") and Convex Capital Limited ("Convex")

 

The Group's professional services businesses RBGLS which holds the Company's two client-facing brands ('Rosenblatt', and 'Memery Crystal)', and Convex have had a robust performance year-to-date, despite the market headwinds.

 

As a result, RBGLS is on track to exceed the Board's expectations for the full year, whilst Convex has some transactions which are now expected to complete in Q1 2023, with deferment of revenue into the new financial year. Together, the professional services businesses will be marginally ahead of the Board's expectations for the year.

 

LionFish Litigation Finance Limited ("LionFish")

The Group's litigation finance subsidiary, LionFish has recently lost two of the cases that it has invested in and following a review, the Board has now concluded that any further appeals on these cases are no longer viable.

 

As a result, LionFish will now have a non-cash write-off of £4.0m in 2022 and will, therefore, miss the Board's previous expectations of £2.3m profit. The actual cash loss associated with these cases amounts to £1.1m over the life of the investment.

 

Committed funding on the on-going Lionfish cases is £3.3m over the next two years.

 

The Board has been reviewing its strategy with respect to third party litigation funding through LionFish with a view to reducing the Group's ongoing exposure to the remaining committed funding. The Group expects to make a further announcement after the year-end.

 

Dividend

As a result of the strong performance in the professional service businesses, the Group intends to announce as planned a second interim dividend for the twelve months to 31 December 2022 in its full year trading statement in January 2023 in line with its policy of distributing up to 60% of retained profits.

 

Balance Sheet

As highlighted above, losses arising from the unsuccessful Litigation Finance cases have no further impact on the Group's cash position and the Group's balance sheet remains in line with the Board's expectations. Free cash flow generation at Group level has remained positive and strong across 2022. The Group continues to trade within its facility agreements and retains sufficient headroom to execute on its strategy.

 

Outlook

RBGLS continues to trade robustly and Convex has a strong pipeline of deals which remain in process. As a result of the case losses in LionFish, the Group now expects adjusted EBITDA to be materially behind current market consensus expectations for 2022 and in a range of between £11.0m-£12.0m. The Board is confident in the medium and long-term outlook of the business.

 

Commenting Group CEO Nicola Foulston, said: "I am very disappointed with the LionFish position. We are taking steps to address the ongoing exposure to this subsidiary. We will also look at the efficiency of the cost base so that in 2023 we continue to deliver strong cash generation and good yield.

 

"I am pleased to see the robust trading of our professional services business, which follows a strong 2021 financial year. We are seeing the benefits of the integration of Memery Crystal and Rosenblatt with improved operating efficiency driving higher margins. While there is some disruption from difficult market conditions, Convex continues to benefit from its model of deep deal origination around the demands of buyers for good businesses.

 

"As we refocus the Group on Professional Services business, we are excited at the potential to grow the businesses organically and drive opportunities for cross-selling.

 

"We are confident in the medium to long-term outlook of the business and are looking forward to the next 12 months with optimism, despite the ongoing economic uncertainty."

 

Enquiries:

RBG Holdings plc Nicola Foulston, CEO

 

 Via SEC Newgate

 

Singer Capital Markets (Nomad and Broker) Rick Thompson / Alex Bond / James Fischer (Corporate Finance)Tom Salvesen (Corporate Broking)

 

Tel: +44 (0)20 7496 3000

SEC Newgate (for media enquiries) Robin Tozer

Tel: +44 (0)7540 106366 

rbg@secnewgate.co.uk

 

 

About RBG Holdings plc

RBG Holdings plc is a professional services group, which comprises the following divisions:

 

RBG Legal Services Limited ("RBGLS")

RBGLS is the Group's legal services division which combines the businesses previously operated by Rosenblatt Limited and Memery Crystal LLP.

 

Rosenblatt

Rosenblatt is one of the UK's pioneering legal practices and a leader in dispute resolution. Rosenblatt provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs and individuals. Complementing this is Rosenblatt's increasingly international footprint, advising on complex cross-jurisdictional disputes.

 

Memery Crystal

Memery Crystal offers legal services in a range of areas such as corporate (including a market-leading corporate finance offering), real estate, commercial, IP & technology (CIPT), banking & finance, tax & wealth structuring and employment. Memery Crystal is one of the leading legal practices in the UK to advise the emerging cannabis sector on a wide range of business issues. Memery Crystal offers a partner-led service to a broad range of clients, from multinational companies, financial institutions and owner-managed businesses to individual entrepreneurs.

 

 

Convex Capital Limited ("Convex Capital")

Convex Capital is a specialist sell-side corporate finance boutique based in Manchester. Convex Capital is entirely focused on helping companies, particularly owner-managed and entrepreneurial businesses, realise their value through sales to large corporates. Convex Capital identifies and proactively targets firms that it believes represent attractive acquisition opportunities.

 

LionFish Litigation Finance Limited ("LionFish")

The Group also provides litigation finance in selected cases through a separate arm, LionFish Litigation Finance Limited. LionFish finances litigation matters being run by other solicitors in return for a significant return on the outcome of those cases. As such, the Group has two types of litigation assets - Rosenblatt's own client matters, and litigation matters run by third-party solicitors. LionFish is positioned to be a unique, alternative provider to the traditional litigation funders.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSAARUOUURUA
Date   Source Headline
28th Jan 20219:05 amRNSSecond Price Monitoring Extn
28th Jan 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSTrading Update & Investor Presentation
5th Jan 202112:05 pmRNSHolding(s) in Company
11th Nov 202010:00 amRNSPurchase of shares / PDMR Shareholding
6th Oct 20207:00 amRNSTrading & Market Guidance Update
16th Sep 20202:06 pmRNSSecond Price Monitoring Extn
16th Sep 20202:00 pmRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSUnaudited Interim Results
2nd Sep 20201:18 pmRNSRetail Investor Presentation
14th Jul 20207:00 amRNSLaunch of financing solution for insolvency claims
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSPre-close Trading Update
18th Jun 20201:53 pmRNSResult of AGM
1st Jun 20207:00 amRNSAppointment of Broker
20th May 20207:00 amRNSDividend Update and AGM Arrangements
21st Apr 20207:00 amRNSFull Year Results
16th Apr 20207:00 amRNSLitigation Investment Update
6th Apr 20207:00 amRNSTrading and COVID-19 Update
6th Feb 20203:58 pmRNSAppointment of Joint Broker
5th Feb 20202:35 pmRNSChange of Website
24th Jan 20207:00 amRNSTrading Update & Directorate Change
6th Jan 20207:01 amRNSLord Hogan-Howe appointed as an adviser
6th Jan 20207:00 amRNSSettlement of Project Blue Sky
29th Nov 20197:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:25 amRNSDirector/PDMR Shareholding
26th Sep 20195:25 pmRNSDividend Declaration
25th Sep 20197:00 amRNSUnaudited Interim Results
16th Sep 20197:00 amRNSAcquisition of Convex Capital Limited
9th Sep 20197:00 amRNSNew White Collar Fraud & Financial Crime Division
1st Aug 20197:00 amRNSTrading and Dividend Update
31st Jul 20194:35 pmRNSChange of Adviser
17th Jul 20192:26 pmRNSDirector/PDMR Shareholding
18th Jun 20193:55 pmRNSResult of Annual General Meeting
21st May 20197:00 amRNSPosting of Annual Report and Accounts
2nd May 20195:09 pmRNSDirector/PDMR Shareholding
30th Apr 20198:00 amRNSAnnual Report and Notice of Annual General Meeting
30th Apr 20197:00 amRNSPreliminary Results & Dividend Declaration
4th Feb 20197:00 amRNSTrading and Dividend Update
24th Jan 20197:00 amRNSAppointment of Non-Executive Director
11th Jan 20197:00 amRNSAppointment of Chief Financial Officer
18th Sep 20187:00 amRNSUnaudited Interim Results
23rd Aug 20187:00 amRNSBoard Changes
3rd Aug 20184:20 pmRNSNotice of Results
12th Jul 201812:51 pmRNSBoard Change
22nd May 20184:45 pmRNSHolding(s) in Company
10th May 20184:23 pmRNSHoldings in Company
10th May 20182:22 pmRNSHoldings in Company
10th May 20189:18 amRNSHoldings in Company
9th May 20183:00 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.